English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Mar 22, 2026

Sana’s cell therapy sustains insulin production through 14 months in a T1D patient
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

Structure Therapeutics reports competitive results for oral weight loss drug in Phase 2 study
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

White House urges Kennedy to shift vaccine stance as election approaches
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

Expert discusses impact of reality TV disclosures on sexual trauma healing
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

Penn researchers receive up to $7.8 million for lymphatic system imaging project
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

Study links sleep-like brain activity to attention lapses in adults with ADHD

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes